Delivery Order SPE2DB24D2205-SPE2DB25FEGGC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages) with a ceiling value of $1,016.35. This competitive award, utilizing firm fixed pricing, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from AmerisourceBergen's...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $1,295.32 for Mucinex D ER 600-60 mg tablets (18-count). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,013.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count units) on July 24, 2025, with completion targeted for July 25, 2025. This non-set-aside delivery order represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. The award was issued to AmerisourceBergen's Corporate Office division, with performance to occur at the company's headquarters in...
- The Defense Logistics Agency awarded a $1,472.20 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages). This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Performance is scheduled for completion by July 22, 2025, with fulfillment based at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,389.38 on August 13, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count package). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order valued at $1,410.00 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages). This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competitive set-aside. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,530.72 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count units) with an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under DLA's pharmaceutical procurement framework. The award represents a routine replenishment of over-the-counter cough and cold medication for federal medical supply needs, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mucinex D ER 600-60 mg tablets (18-count packages) with a ceiling value of $1,509.56. This competitive, firm fixed-price delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,877.76 to AmerisourceBergen Drug Corp for the supply of Mucinex D ER 600-60 mg tablets (18-count units). The contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a $1,091.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Mucinex ER 600 mg, with an ultimate completion date of July 25, 2025. This competitively awarded contract, which carries no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical supply will...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGGCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count) with a ceiling value of $4,116.27. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical products will be delivered to the company's distribution location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor for the Defense Logistics Agency's Medical Supply Chain, supporting military and veteran healthcare systems. The company's DLA Pharmaceutical Prime Vendor Global Program contract enables it to supply a comprehensive range of pharmaceutical products and medical supplies—including brand-name and generic medications, vaccines, and specialized healthcare commodities—to support military healthcare programs worldwide. This delivery order for over-the-counter cold and cough medication reflects the company's broad portfolio of medical product deliveries supporting Defense Health Agency requirements and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 8/14/25 |